Case Report
Copyright ©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 21, 2012; 18(35): 4962-4966
Published online Sep 21, 2012. doi: 10.3748/wjg.v18.i35.4962
Table 1 Patients with esophageal carcinoma and skeletal muscle metastases in the present series
PatientAge at diagnosis (yr)HistologyStage at diagnosisTimingPrimary therapyMetastatic interval (mo)SymptomsDiagnosisLocationOther metastasesTherapy for muscle metastasesSurvival from the diagnosis of muscle metastasis (mo)
164AdenoIIMetachronousCXRT32MassPET/CT; biopsyQuadriceps femorisB; LN (subs)CXRT31
276SCCIIIMetachronousCXRT5NonePET/CT; biopsyGluteus minimus; psoasL; P; A; LN (subs)CXRT16
357SCCIVSynchronousNone0NonePET/CTSubscapularisBCRT; subs XRT5
442AdenoIVSynchronousCXRT0NonePET/CT; biopsyIliacusPRS16
560SCC; adeno (pancreas)IVSynchronousNone0NonePET/CT; autopsyMultipleMultipleNone2
Table 2 Overview of the reports of esophageal carcinoma skeletal muscle metastases
Ref.SexAge (yr)HistologyTimingSymptomsDiagnosisLocation of muscle metastasesOther metastasesTherapyOutcome
Heyer et al[18]M54AdenoSynchronousAsymptomatic; fortuitously detected during CTCT; MRI; biopsyMultipleNoneCXRT (to the primary)ND
Rehman et al[19]M71AdenoNDPain; unable to walkMRI; biopsyThighNDXRT (metastases)Symptomatic relief 2 wk later
Kozyreva et al[20]M72Adeno (T3N1Mx)SynchronousAsymptomatic; fortuitously detected during PET/CTPET/CT; biopsyDeltoidNoneC (oxaliplatin + 5FU/FA)Progression of muscle metastases
Schultz et al[5]NDNDSCCSynchronousNDCT; biopsyGluteus minimusNDNDND
Heffernan et al[21]F67Adeno5 mo after surgeryAsymptomatic; fortuitously detected during PET/CTPET/CTMultipleMediastinumNDND
Wu et al[22]M67AdenoSynchronousAsymptomatic; fortuitously detected during PET/CTPET/CT; biopsyGluteus minimusNoneNDND
Lekse et al[23]F78Adeno4 mo after diagnosisDiplopiaCT; biopsyInferior rectus ocularLungSymptomaticND
Lekse et al[23]M78Adeno2 mo after diagnosisDiplopia; loss of visionMRILateral rectus ocularLung; bone; liverXRT; C (5FU + FA)ND